In the present study we provide evidence that 3,3 0 ,5 0 -triiodothyronine (reverse T 3 , rT 3 ) restores neurochemical parameters induced by congenital hypothyroidism in rat hippocampus. Congenital hypothyroidism was induced by adding 0.05% propylthiouracil in the drinking water from gestation day 8 and continually up to lactation day 15. In the in vivo rT 3 exposure, hypothyroid 12-day old pups were daily injected with rT 3 (50 ng/kg body weight) or saline until day 14. In the ex vivo rT 3 treatment, hippocampal slices from 15-day-old hypothyroid pups were incubated for 30 min with or without rT 3 (1 nM). We found that ex vivo and/or in vivo exposure to rT 3 failed in restoring the decreased 14 C-glutamate uptake; however, restored the phosphorylation of glial fibrillary acidic protein (GFAP), 45 Ca 2þ influx, aspartate transaminase (AST), glutamine synthetase (GS) and gamma-glutamate transferase (GGT) activities, as well as glutathione (GSH) levels in hypothyroid hippocampus. In addition, rT 3 improved 14 C-2-deoxy-Dglucose uptake and lactate dehydrogenase (LDH) activity. Receptor agonists/antagonists (RGD peptide and AP-5), kinase inhibitors of p38MAPK, ERK1/2, CaMKII, PKA (SB239063, PD98059, KN93 and H89, respectively), L-type voltage-dependent calcium channel blocker (nifedipine) and intracellular calcium chelator (BAPTA-AM) were used to determine the mechanisms of the nongenomic rT 3 action on GGT activity. Using molecular docking analysis, we found rT 3 interaction with avb3 integrin receptors, nongenomically activating signaling pathways (PKA, CaMKII, p38MAPK) that restored GGT activity. We provide evidence that rT 3 is an active TH metabolite and our results represent an important contribution to elucidate the nonclassical mechanism of action of this metabolite in hypothyroidism.
a b s t r a c t
In the present study we provide evidence that 3,3 0 ,5 0 -triiodothyronine (reverse T 3 , rT 3 ) restores neurochemical parameters induced by congenital hypothyroidism in rat hippocampus. Congenital hypothyroidism was induced by adding 0.05% propylthiouracil in the drinking water from gestation day 8 and continually up to lactation day 15. In the in vivo rT 3 exposure, hypothyroid 12-day old pups were daily injected with rT 3 (50 ng/kg body weight) or saline until day 14. In the ex vivo rT 3 treatment, hippocampal slices from 15-day-old hypothyroid pups were incubated for 30 min with or without rT 3 (1 nM). We found that ex vivo and/or in vivo exposure to rT 3 failed in restoring the decreased 14 C-glutamate uptake; however, restored the phosphorylation of glial fibrillary acidic protein (GFAP), 45 Ca 2þ influx, aspartate transaminase (AST), glutamine synthetase (GS) and gamma-glutamate transferase (GGT) activities, as well as glutathione (GSH) levels in hypothyroid hippocampus. In addition, rT 3 improved
Introduction
Thyroid hormones (TH), 3,5,3 0 -triiodo-L-thyronine (T 3 ) and thyroxine (T 4 ), are involved in metabolic and physiological functions of several tissues, being crucial for neural development and function (Bernal, 2007; Bernal et al., 2003) . The classical mechanism of hormone action involves the modulation of gene expression. However, several evidence point to nongenomic mechanisms of TH in different cell types, including neural cells (Dusart and Flamant, 2012; Morte and Bernal, 2014; Galton et al., 2007; Zamoner et al., 2005; Manzano et al., 2007; Gilbert et al., 2007; Madeira et al., 1988; Zamoner et al., 2007a Schmohl et al., 2015; Lischinsky et al., 2016; Zanatta et al., 2013a; Bernal et al., 2003) . The nongenomic actions of TH might be associated with surface receptor-, as well as kinase-and/ or calcium-activated signaling pathways (Morte and Bernal, 2014; Gilbert et al., 2007; Zamoner et al., 2007a; Schmohl et al., 2015; Bernal et al., 2003; Davis et al., 2010; Bergh et al., 2005) .
In the central nervous system (CNS), TH are essential for myelination (Bauer and Whybrow, 2001) , neuritogenesis (FernandezLamo et al., 2009) , maturation of neurotransmitter systems (Bauer and Whybrow, 2001) , synaptic plasticity (Vallortigara et al., 2008 (Vallortigara et al., , 2009 Zamoner et al., 2007b) , intermediate filament phosphorylation (Gilbert et al., 2007; Zamoner et al., 2007b; Schmohl et al., 2015) as well as regulation of ion channels (Madeira et al., 1988) .
Besides T 3, known as the classical TH, TH metabolites exist, including 3,3 0 ,5-triiodothyroacetic acid (triac); tetraiodothyroacetic acid (tetrac); 3,3 0 ,5 0 -triiodo-L-thyronine (reverse T 3 , rT 3 ) and 3,5-diiodo-L-thyronine (T 2 ).
Triac is produced by the liver and other tissues (Siegrist-Kaiser and Burger, 1994) and several reports support that it is a biologically active metabolite (Medina-Gomez et al., 2003; Dumas et al., 1982; Kunitake et al., 1989) .
Tetrac binds to the TH receptor on the extracellular domain of the plasma membrane integrin avb3 protein and modulates multiple intracellular activities regulated by the receptor (Bergh et al., 2005; Cody et al., 2007) . Otherwise, both rT 3 and T 2 were considered inactive metabolites produced by TH deiodination. The iodothyronine deiodinase 3 (D3) degrades T 4 to rT 3 and T 3 to T 2 (Araujo and Carvalho, 2011; Sibilio et al., 2012) . However, several reports have recently shown that they may have relevant biological effects in different cell types (Plow et al., 2000; Farwell et al., 2005; Zanatta et al., 2013) . In this context, T 2 was found to be a peripheral mediator of several TH metabolic effects (Moreno et al., 2002) and findings previously reported in hypothyroid rats suggest that T 2 has specific actions on resting metabolic rate (Lanni et al., 1996) .
The evidence supporting rT 3 as a metabolically active TH comes from several reports on the restoring activity of this TH on the cytoskeleton of hypothyroid rat brain challenging previous understanding that rT 3 is a biologically inactive molecule. In this context, T 4 and rT 3 , but not T 3 , were able to restore the levels of filamentous actin (F-actin) into cerebellar cells of hypothyroid neonate rats (Faivre-Sarrailh and Rabie, 1988; Farwell et al., 2006; Leonard, 2008) , in which rT 3 acted as a potent initiator of actin polymerization in astrocytes.
In hypothyroid rodents, neurons and astrocytes develop poor actin cytoskeletons that T 3 replacement cannot rescue. However, rT 3 initiates reappearance of filamentous actin within minutes, without altering total actin mRNA or protein content (Farwell et al., 1990; Siegrist-Kaiser et al., 1990) . This rT 3 property was attributed to TRDa1, a native thyroid receptor (TR) isoform that lacks a nuclear localization signal and is present in the extra nuclear compartment of astrocytes and neurons. This isoform has the ligand affinity and specificity required for actin polymerization by rT 3 . Astrocytes of the developing mouse cerebellum deprived of both TRs showed that TRDa1 rescued the actin cytoskeleton response to rT 3 (Flamant and Samarut, 2003) .
The brain is the predominant D3-expressing tissue in adult animals, and may thus be the main site for the clearance of plasma T 3 and for the production of plasma rT 3 (Peeters and Visser, 2000) .
Hypothyroidism is a condition in which the serum levels of THs are below that necessary to carry out physiological functions in the body. Central congenital hypothyroidism is a rare disorder in which inadequate TH biosynthesis occurs due to defective stimulation of a normal thyroid gland by thyroid stimulating hormone (TSH) (Schoenmakers et al., 2015) . Thyroid hormone deficiency during fetal and postnatal development results in several biochemical and morphological changes in the neonatal rat brain, such as altered number of neurons and astrocytes, reduced synaptic connectivity, delayed myelination, disturbed neuronal migration, modifications in neurotransmission leading to deleterious effects for central nervous system development (Bernal, 2015) .
Hypothyroidism may decrease the ability to induce long-term potentiation (LTP), compromising learning and memory formation. In this context, we previously demonstrated that congenital hypothyroidism decreases the astrocyte protein levels of glial fibrilary acidic protein (GFAP) and glutamate transporters (GLAST and GLT-1) in cerebral cortex of immature rats. These events clearly demonstrate misregulated astrocyte function and glutamate homeostasis (Zamoner et al., 2008a) . Corroborating our findings, AlvaSanchez and colleagues have demonstrated that the neuronal damage in the hippocampus of hypothyroid animals requires activation of the ionotropic glutamate receptor N-methyl-D-aspartate (NMDA) (Alva-Sanchez et al., 2009) . Moreover, it has been demonstrated that hypothyroid rats are extremely vulnerable to proconvulsant neurotoxic effects of kainite (Gine et al., 2010) . These events might be related to glutamatergic excitotoxicity, corroborating recent results of our research group, which demonstrated that congenital hypothyroidism decreases glutamate uptake, increases Ca 2þ influx and induces oxidative stress in rat hippocampus (Cattani et al., 2013) . In addition, the TH actions in brain might be triggered by either genomic or nongenomic signaling mechanisms. Accordingly, the avb3 integrin dimer has been suggested as a putative plasma membrane receptor for TH, with higher affinity for T 4 and rT 3 than for T 3 (Plow et al., 2000; Bergh et al., 2005) . On the other hand, the nuclear receptor for TH interacts preferentially with T 3 , being less responsive for T 4 and rT 3 (Davis et al., 2008) .
Considering our previous data and evidence in the literature that rT 3 could play biological roles in hypothyroid rat brain, in the present study we addressed the ability of rT 3 in restoring the homeostasis of glutamate metabolism in hypothyroidism, assessing signaling pathways and the role of integrin receptor avb3 in the rT 3 actions. In addition, we searched for the implication of rT 3 on the energetic metabolism and the homeostasis of the intermediate filament (IF) cytoskeleton of astrocytes. We used an experimental model of congenital hypothyroidism in rats focusing on genomic and nongenomic mechanisms of action of rT 3 through short-term ex vivo and classical in vivo actions of rT 3 in the hippocampus of immature pups. Special attention was given to the signaling pathways implicated in the action of rT 3 on gamma-glutamyl transferase (GGT) activity. We used molecular docking analysis to propose that the actions of rT 3 could be downstream of avb3 integrin receptor. 
Experimental procedures
, 2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059), benzamidine, leupeptin, antipain, pepstatin, chymostatin, acrylamide, bisacrylamide, 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580), Triton X-100, 3,5 0 ,3 0 -triiodo-Lthyroinine (reverse T 3 , rT 3 ) and Arg-Gly-Asp peptide (RGD) were purchased from Sigma Chemical Company (St. Louis, MO, USA). All reagents used for stock solutions were of analytical grade.
Animals
Wistar rats were obtained from our breeding stock. Rats were maintained on a 12-h light/12-h dark cycle in a constant temperature (22 C) colony room. On the day of birth the litter size was culled to eight pups. Litters smaller than eight pups were not included in the experiments. Dams were provided ad libitum with water and the Nuvilab CR-1 irradiated chow obtained from Nuvital (Curitiba, PR, Brazil) containing 22% protein (g/kg/diet), 4.3 kcal/g, supplemented with vitamins, mineral microelements, L-lysine, Lmethionine and antioxidants. The animals were observed for clinical signs of toxicity related to rT 3 treatment. All experimental procedures were conducted in accordance to the rules and laws of ethical recommendations of the local Ethical Committee for Animal Use at Federal University of Santa Catarina (Protocol Number: CEUA-UFSC/PP00318 and CEUA-UFSC/PP00820), which is in accordance with Brazilian Council for Control of Animal Experimentation (CONCEA). Pups from multiple PTU-exposed and control dams were used in each experiment. Results were obtained at least from three independent experiments using three or four animals per group in each experiment.
Induction of congenital hypothyroidism
Wistar rats were mated and the day of appearance of the vaginal plug was considered day 0 of fetal age. Adding 0.05% 6-propyl-2-thiouracil (PTU) in the drinking water from gestation day 8 and continually up to lactation day 15 induced congenital hypothyroidism (Zamoner et al., 2008b; Cattani et al., 2013) . Euthyroid rats received only water during the same period. Each experiment was carried out by treating dams during pregnancy and lactation, and the pups from their litters were used to investigate the effects of rT 3 on hippocampal cells. Experiments were carried out with 15-day old pups. All animals were monitored daily and we did not observe any visible external malformations or signs of pain and/or distress such as piloerection, increased aggression, excessive licking/scratching, reduction of appetite or increased/decreased movement. In addition, the congenital hypothyroidism did not cause mortality within-litter. Otherwise, the PTU treatment leads to decreased body mass gain of pups (data not shown).
In vivo treatment with rT 3
Hypothyroid male Wistar pups received i.p. injections of rT 3 (50 ng/kg body weight) or saline for 3 consecutive days from the 12th day postnatal age and the experiments were performed 24 h after the last injection, when the animals were 15 days old.
Ex vivo treatment with rT 3
For all experiments with ex vivo treatment with the rT 3 , hippocampal slices were pre-incubated for 15 min at 37 C in Hank's balanced saline solution (HBSS in mM; 1.29 CaCl 2 , 136.9 NaCl, 0.36 KCl, 0.65 MgSO 4 , 0.27 Na 2 HPO 4 , 1.1 KH 2 PO 4 , 2 D-glucose and 5 Hepes) or the specific buffers described below, followed by 30 min incubation with or without the 1nM rT 3 .
Preparation of hippocampal slices
Rats were euthanized by decapitation, the hippocampus was dissected onto Petri dishes placed on ice and the hippocampus was cut into 400 mm thick slices with a McIlwain chopper.
2.7. Glial fibrillary acidic protein (GFAP) phosphorylation 2.7.1. In vitro 32 P incorporation Hippocampal slices were initially preincubated at 30 C for 20 min in a Krebs-Hepes medium containing in mM: 124 NaCl, 4 KCl, 1.2 MgSO 4 , 25 Na-HEPES (pH 7.4), 12 glucose, 1 CaCl 2 , and the following protease inhibitors: 1 mM benzamidine, 0.1 mM leupeptin, 0.7 mM antipain, 0.7 mM pepstatin and 0.7 mM chymostatin.
After preincubation, the medium was changed and incubation was carried out at 30 C with 100 ml of the basic medium containing 80 mCi of [ 32 P] orthophosphate, with or without addition of 1 nM rT 3 when indicated. The labeling reaction was normally allowed to proceed for 30 min at 30 C and stopped with 1 ml of cold stop buffer (in mM) (150 NaF, 5 EDTA, 5 EGTA, 50 Tris-HCl, pH 6.5, and the protease inhibitors described above). Slices were then washed twice with stop buffer to remove excess radioactivity. After treatment, preparations of intermediate filament (IF)-enriched cytoskeletal fractions were obtained from hippocampus of 15-day-old male rats. Briefly, after the labelling reaction, slices were homogenized in 400 ml of ice-cold high salt buffer containing in mM: 5 KH 2 PO 4 , (pH 7.1), 600 KCl, 10 MgCl 2 , 2 EGTA, 1 EDTA, 1% Triton X-100 and the protease inhibitors described above. The homogenate was centrifuged at 15,800Âg for 10 min at 4 C, in an Eppendorf centrifuge, the supernatant discarded and the pellet homogenized with the same volume of the high salt medium. The suspended homogenate was centrifuged as described and the supernatant was discarded. The Triton-insoluble IF-enriched pellet, containing GFAP was dissolved in 1% SDS and the protein concentration was determined (Lowry et al., 1951) .
Polyacrylamide gel electrophoresis (SDS-PAGE)
The cytoskeletal fraction was prepared as described above. For electrophoresis analysis, samples were dissolved in 25% (v/v) of a solution containing 40% glycerol, 5% mercaptoethanol, 50 mM TrisHCl, pH 6.8 and boiled for 3 min. Equal protein concentrations were loaded onto 10% polyacrylamide gels and analyzed by SDS-PAGE according to the discontinuous system of (Laemmli, 1970) . The gels containing the IF-enriched cytoskeletal fraction were exposed to X-ray films (T-mat G/RA) at À70 C with intensifying screens.
Quantification of 32 P incorporation into GFAP
The radioactivity incorporated into GFAP was quantified by scanning the films with a Hewlett-Packard Scanjet 6100C scanner and by determining optical densities with an OptiQuant software version 02.00 (Packard Instrument Company). Optical density values were obtained for the band corresponding to GFAP. Control values were then normalized to 100% and the percentage changes in the test samples were calculated. Protein loading was controlled by Coomassie Blue staining gels.
2.8.
14 C-glutamate uptake
For glutamate uptake, the incubation medium was replaced by Hank's balanced salt solution (HBSS) containing in mM: 137 NaCl, 0.63 Na 2 HPO 4 , 4.17 NaHCO 3 , 5.36 KCl, 0.44 KH 2 PO 4 , 1.26 CaCl 2 , 0.41 MgSO 4 , 0.49 MgCl 2 , and 5.55 glucose, pH 7.4. The hippocampal slices pre-incubated in HBSS during 15 min. Then, glutamate uptake assay was started by the addition of 0.1 mM L-glutamate and 0.33 mCi/mL [ 14 C] glutamate (Cesconetto et al., 2016) . Incubation was stopped after 10 min by removal of the medium and rinsing the slices twice with ice-cold HBSS. Slices were then lysed in a solution containing 0.5 M NaOH. Sodium-independent uptake was determined using N-methyl-D-glucamine instead of sodium chloride. Sodium-dependent glutamate uptake was obtained by subtracting the nonspecific uptake from the specific uptake. Radioactivity was measured with a scintillation counter. (Zamoner et al., 2007b) . After washing, tissue slices were digested and homogenized with 0.5 M NaOH solution, 100 mL aliquots were placed in scintillation fluid and counted in a LKB rack beta liquid scintillation spectrometer (model LS 6500; Multi-Porpose Scintillation Counter-Beckman Coulter, Boston, USA), and 5 mL aliquots were used for protein quantification as described by (Lowry et al., 1951) .
For the [U-14 C]-2-deoxy-D-glucose ( 14 C-DG) uptake experiments, the hippocampal slices from euthyroid and hypothyroid pups were pre-incubated for 30 min at 37 C in Krebs Ringerbicarbonate (KRb) buffer with a composition of 5.6 mM glucose, 122 mM NaCl, 3 mM KCl, 1.2 mM MgSO 4 , 1.3 mM CaCl 2 , 0.4 mM KH 2 PO 4 , and 25 mM NaHCO 3 and bubbled with O 2 /CO 2 [95%:5%, v/ v] until pH 7.4. Then the slices were incubated for 30 min with 14 C-DG (0.1 mCi/mL; 0.12 nM) in the presence or absence of 1 nM rT 3 , when indicated. After incubation, slices were lysed in a solution containing 0.5 M NaOH. Aliquots were used for the total protein quantification and results were expressed as mg glucose/mL/mg of protein (Cesconetto et al., 2016) .
Measurement of lactate dehydrogenase (LDH) activity
The hippocampal slices from 15-day-old euthyroid and hypothyroid rats were preincubated for 15 min in KRb buffer, followed by incubation with or without rT 3 (1 nM) during 30 min. Then, tissue slices were homogenized in cold 0.2 M Tris buffer, pH 7.4 and the LDH activity was determined by a spectrophotometric method (Bermeyer and Bergmeyer, 1983) . The estimation of LDH activity was carried out by measuring the oxidation of NADH to NAD þ and the results were expressed as U/L/mg of protein.
Measurement of transaminase activity
The hippocampal slices from euthyroid and hypothyroid rats were preincubated for 15 min in KRb buffer, followed by incubation with or without rT 3 (1 nM) during 30 min. Slices of hippocampus (exposed to rT 3 in vivo or ex vivo) were homogenized in cold 0.2 M Tris buffer, pH 7.4. Sample aliquots were saved for total protein determinations (Lowry et al., 1951) . The enzymatic activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were quantified in aliquots of the tissue homogenate by using the colorimetric method described by (Reitman and Frankel, 1957) , with modifications. Results for enzyme activity were obtained by using calibration curves based on non-chromogenic absorbance. The absorbance of the samples was determined in a plate reader (Tecan Infinite ® 200 PRO) at 505 nm. The results were expressed as U/L/mg protein.
Measurement of glutamine synthetase (GS) activity
The GS activity was determined according to Petito et al. (1992) . Briefly, homogenate (0.1 ml) was added to 0.1 ml of reaction mixture containing in mM: 10 MgCl 2 , 50 L-glutamate, 100 imidazoleeHCl buffer (pH 7.4), 10 2-mercaptoethanol, 50 hydroxylamineeHCl, and 10 ATP and incubated for 15 min at 37 C. The reaction was stopped by the addition of 0.4 ml of a solution containing in mM: 370 ferric chloride, 670 HCl, and 200 trichloroacetic acid (TCA). After centrifugation, the supernatant was measured at 530 nm and compared to the absorbance generated by standard quantities of c-glutamyl hydroxamate treated with ferric chloride reagent.
Measurement of glutathione (GSH) content
GSH content was determined as described by (Browne and Armstrong, 1998) . Briefly, slices were homogenized in sodium phosphate buffer (0.1 M, pH 8.0) containing 0.005 M EDTA and protein was precipitated with 1.7% meta-phosphoric acid. Supernatant was assayed with o-phthaldialdeyde (1 mg/mL of methanol) at room temperature for 15 min. Fluorescence was measured using excitation and emission wavelengths of 350 and 420 nm, respectively. A calibration curve was performed with standard GSH solutions (0e500 mM). GSH concentrations were calculated as nmol/ mg protein.
Measurement of gamma-glutamyl transferase (GGT) activity
For enzymatic activity, hippocampal slices were preincubated for 15 min in KRb buffer, followed by incubation with or without rT 3 (10 À9 M) during 30 min. The mechanistic approach on GGT activity was carried out by adding 10 mM KN93 (CaMKII inhibitor); 10 mM H89 (PKA inhibitor); 50 mM BAPTA-AM (cell-permeable Ca þþ chelator); 10 mM AP-5 (NMDA-type glutamate receptor antagonist); 500 nM RGD (avb3 integrin antagonist); 10 mM SB239063 (p38 MAPK inhibitor); 30 mM PD98059 (MAPK inhibitor) or 10 mM nifedipine (L-VDCC blocker) during the preincubation and incubation periods, in the presence or absence of rT 3 , when indicated. After incubation time, tissue was homogenized in cold 0.1 M Tris buffer, pH 8.5 (10% homogenate w/v) to determine GGT activity Sample aliquots were saved for total protein determinations (Lowry et al., 1951) . GGT activity was measured by using the method previously described by (Orlowski and Meister, 1963) , using L-g-glutamyl p-nitroanilide as substrate and glycylglycine as the acceptor molecule.
Aliquots of the tissue homogenate prepared as described above were incubated with the enzymatic substrate. The reaction was allowed to proceed for 60 min at 37 C and the enzymatic reaction was stopped by addition of acetic acid. The absorbance of the samples was determined in a plate reader (Tecan Infinite ® 200 PRO) at 530 nm. The results were expressed as U/L/mg protein.
Molecular docking analysis
Autodock vina software (Trott and Olson, 2010) was used for molecular docking. The integrin receptor (PDB 1L5G) was prepared for docking using Chimera 10.1 (Pettersen et al., 2004) at default parameters, considering pH 7, and the AMBER force field was used (Wang et al., 2004) . Reverse T 3 ligand was selected from Zinc database, code 4097418 (http://zinc.docking.org). Flexible residues, 3 Å from ligand bound center (RGD peptide binding site from integrin), was used for running dock analysis. The lower DG pose with lower RMSD to the crystallographic ligand was selected for ligand binding analysis with LigPlot software (Wallace et al., 1996) .
Statistical analysis
Data were obtained from euthyroid and hypothyroid animals originated from multiple dams in each experiment assuring the genetic variability in our experimental condition. All results are represented as means ± S.E.M. Statistically significant differences from controls were determined by one-way ANOVA and post hoc tests with multiple comparisons (Tukey-Kramer) posttests or twoway ANOVA using GraphPad InStat version 3.01 and GraphPad Prism version 5.0, GraphPad software Inc, (La Jolla, California, USA). Differences were considered to be significant when p < 0.05.
Results and discussion
Our group (Zamoner et al., 2008a (Zamoner et al., , 2008b Cattani et al., 2013) previously described the animal model of congenital hypothyroidism we used in the present study. We assessed the metabolic roles of rT 3 through different experimental approaches. In the ex vivo approach, hippocampal slices of 15-day-old hypothyroid rats were incubated with 1 nM rT 3 for 30 min and we assessed the short-term effects of the hormone, compatible with the nongenomic mechanism of action of TH (Bernal et al., 2003; . In the in vivo approach of rT 3 treatment, hypothyroid 12-day-old pups were daily injected with rT 3 (50 ng/kg body weight) until day 14. Biochemical analyzes were carried out in hippocampal slices 24 h after the last hormone injection (15-day-old pups). This long-term exposure allowed us to assess the genomic actions of the hormone.
Initially, we addressed the ability of rT 3 in restoring the homeostasis of the phosphorylating system associated with the IFenriched cytoskeleton of astrocytes in the hippocampus of hypothyroid pups.
Effect of rT 3 on the homeostasis of GFAP phosphorylation
We found hyperphosphorylated GFAP in the hippocampus of the hypothyroid pups. Interestingly, the ex vivo rT 3 treatment of hypothyroid hippocampal slices was able to restore the euthyroid levels (Fig. 1) . The GFAP hyperphosphorylation in hypothyroid pups corresponded to 55% of euthyroid levels. Moreover, rT 3 restored the baseline GFAP phosphorylation to normal levels corresponding to 69% of hypothyroid phosphorylation.
Astrocytes express GFAP, the specific astrocytic IF, together with vimentin, nestin and synemin. However, GFAP is the main IF protein expressed in mature astrocytes, where it helps maintaining mechanical strength, as well as cell shape. However, recent evidence has shown that GFAP plays a role in a variety of additional functions, such as cell motility/migration, cell proliferation, glutamate homeostasis, neurite outgrowth and injury/protection (Hol and Pekny, 2015; Pierozan et al., 2016) .
We have previously described that signaling mechanisms involved in the regulation of IF phosphorylation/dephosphorylation are important targets of toxins and metabolites (Pierozan and Pessoa-Pureur, 2017) , including TH (Zamoner et al., 2008a (Zamoner et al., , 2008b . Disrupted phosphorylation of IF proteins is a hallmark of neurodegenerative diseases (Holmgren et al., 2012) in the hippocampus of the hypothyroid pups. Interestingly, our findings showing the ex vivo ability of rT 3 restoring GFAP homeostasis (Fig. 1) corroborate previous evidence that rT 3 is able to target the cytoskeleton in hypothyroid brain (Farwell et al., 1990 (Farwell et al., , 2005 Leonard and Farwell, 1997; Farwell et al., 2005) . Next, we searched for glutamate homeostasis in our hypothyroid model and the ability of rT 3 in restoring this equilibrium. Therefore, we analyzed the Na þ -dependent 14 C-glutamate uptake, also known as X AG system and the Na þ -independent 14 C-glutamate uptake, the x c-system (Danbolt, 2001; Kanai and Hediger, 2003) , since these two types of transport systems are necessary for maintaining brain extracellular glutamate homeostasis (Melendez et al., 2016) . The X AG system is mediated by glutamate transporters such as GLAST and GLT1, predominantly expressed in astrocytes and responsible for the majority (~90%) of total glutamate uptake in the central nervous system. This system is responsible for associating glutamate with Na þ influx, important in maintaining the ionic gradient of the membrane (Barros-Barbosa et al., 2015) . The x c-system acts as an obligate exchanger of intracellular glutamate for extracellular cystine, where cystine is transported into cells and reduced to cysteine for glutathione synthesis (Cho and Bannai, 1990; Bridges et al., 2012) . Our present results show downregulated activities of both X AG and X c-systems in hypothyroid pups. In addition, the ex vivo and in vivo rT 3 treatments of hypothyroid pups failed to restore the homeostasis of these two systems ( Fig. 2A, B, 2D and 2E ). Misregulated glutamate homeostasis could contribute to the cognitive impairments associated with congenital hypothyroidism (Zamoner et al., 2008b; Cattani et al., 2013) , since deficits in either of these glutamate uptake systems are implicated in a number of neurodegenerative and neurocognitive disorders (Choi, 1988) . Moreover, it is largely described that the disrupted homeostasis of extracellular glutamate leads to hyperstimulation of glutamate receptors, associated with glutamate excitotoxicity in the hypothyroid pups (Zamoner et al., 2008b; Cattani et al., 2013) .
Our findings showing downregulated activity of the X AG system of glutamate uptake are consistent with decreased GLAST and GLT- Fig. 1 . Effect of ex vivo rT 3 treatment on hypothyroidism-induced GFAP phosphorylation. Slices of 15-day-old euthyroid and hypothyroid rats were incubated with 32 Porthophosphate in the absence or presence of 1 nM rT 3 during 30 min. The cytoskeletal fraction was extracted, analyzed by SDS-PAGE and the radioactivity incorporated into GFAP was measured by determining the optical density values for the band corresponding to the protein. Data are reported as mean ± SEM of 6 animals in each group and expressed as % of control. Statistically significant differences were determined by one-way ANOVA followed by Bonferroni multiple comparison test are indicated: *P < 0.0001 compared with euthyroid group; #P < 0.0001 compared with hypothyroid group. Representative autoradiograph of IF proteins from IF-enriched cytoskeletal fraction of hippocampal slices were shown. E ¼ euthyroid; H ¼ hypothyroid; H þ rT 3 ¼ hypothyroid þ rT 3 . Arrow indicate the band corresponding to GFAP. 1 immunocontent we have described in this model of congenital hypothyroidism (Zamoner et al., 2008b) .
Consistent with decreased 14 C-L-glutamate uptake, we found upregulated 45 Ca 2þ influx in the hippocampus of hypothyroid pups. This is in line with previously reported results of our group (Cattani et al., 2013) . Results show that rT 3 alters the hypothyroid-induced 45 Ca 2þ influx ex vivo (Fig. 2C ), but not in vivo (Fig. 2F ). Based on our results, we propose that rT 3 might exert this protective effect, through a short-term nongenomic mechanism of action. In this context, rT 3 induced a rapid, but not sustained, modulation of Ca 2þ influx into hippocampal cells, suggesting the involvement of a nongenomic mechanism. Pioneering studies, investigating the nongenomic actions of the T 3 and T 4 , have shown that these hormones induce the influx of Ca 2þ independently of protein synthesis (Segal and Ingbar, 1989; Segal, 1990 (Zanatta et al., 2013) , it is important to emphasize that the present study is the first experimental evidence of rT 3 role as a modulator of Ca 2þ influx in neural cells from hypothyroid rats.
Effect of rT 3 on glutamine synthetase and transaminase activities in hypothyroid rat hippocampus
Intracellular glutamate plays multiple metabolic roles including glutamine synthesis in astrocytes through GS activity. We found decreased GS activity in hypothyroid pups, compatible with misregulated glutamate homeostasis. Interestingly, rT 3 restored the GS activity in both ex vivo and in vivo treatments ( Fig. 3C and F) .
Astrocytes play a key role in the excitatory signaling as they both clear glutamate from the synaptic cleft and house enzymes responsible for glutamate conversion to glutamine. Decreased GS activity in astrocytes could contribute to disrupt the glutamateglutamine cycle, which plays a fundamental role in the glutamate neurotransmission (Schousboe et al., 2014) . Regulation of astrocytic GS is not clearly understood, although studies have indicated GS regulation by hormones (Blutstein et al., 2006) . Therefore, we propose a critical role for rT 3 in restoring GS activity improving the .mg protein À1 and 45 Ca 2þ influx was expressed as pmol Ca 2þ/ mL/mg protein. Statistically significant differences were determined by one-way ANOVA followed by Bonferroni multiple comparison test are indicated: *P < 0.05; **P < 0.01; ***P < 0.01 compared with euthyroid group; #P < 0.05 compared with hypothyroid group.
glutamate-glutamine cycle and glutamatergic neurotransmission of hypothyroid hippocampus (Schousboe et al., 2014) . Another prevalent fate of intracellular glutamate is transamination reactions associating glutamate with energy production through mitochondrial metabolism. Therefore, we analyzed the activities of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), the most prevalent transaminases of animal tissues. These enzymes not only play important roles in intermediary metabolism. In brain, AST and ALT are active neuronal enzymes involved in glutamate metabolism (Kugler, 1993) . In this context, ALT can also be considered as major contributor to the steady-state glutamate levels. Thus, alterations in AST and ALT activities in neural cells would cause energy failure as well as compromise glutamate metabolism. Results showed that ALT activity was not altered either in hypothyroid pups or after ex vivo and in vivo rT 3 treatments (Fig. 3A and D) . Conversely, we found downregulated AST activity in hypothyroid animals and this effect was reversed by both ex vivo and in vivo rT 3 treatments ( Fig. 3B and E) , further supporting a role for this hormone in restoring enzyme activities in our experimental model of congenital hypothyroidism. Downregulated AST activity in hypothyroid pups further supports misregulated glutamate metabolism and reduced mitochondrial metabolism in hypothyroid rat hippocampus (Jojua et al., 2015) . This could implicate energy deficits, impaired neurotransmission and cognitive abnormalities associated with hypothyroidism. Therefore, the role of rT 3 in restoring the AST activity could represent a relevant mechanism counteracting the deleterious effect of energy deficit in hypothyroidism. In this context, it is important to consider that oxaloacetate and a-ketoglutarate, the two alfa-keto acid substrates of AST, are TCA cycle intermediates. Thus, the modulation of the activity of this enzyme by rT 3 reflects the effect of this hormone on the metabolic status of immature hypothyroid rat hippocampus.
Effect of rT 3 on glucose transport and LDH activity in hypothyroid rat hippocampus
In an attempt to better understanding the mechanisms involved in the effects of rT 3 in hypothyroid rat hippocampus, we analyzed the 14 C-DG accumulation after ex vivo and in vivo rT 3 treatments.
Results showed that glucose uptake was not altered by congenital hypothyroidism in hippocampal cells. Otherwise, the ex vivo treatment with rT 3 stimulated 14 C-DG accumulation (Fig. 4A) .
Nonetheless, this effect was not detected in the in vivo treatment with rT 3 (Fig. 4C) , reinforcing the short-term action of the hormone on metabolic parameters and suggesting different ex vivo and in vivo mechanisms involving energy metabolism in hypothyroid hippocampus. Taking into account the increased 14 C-DG accumulation after the ex vivo rT 3 treatment, we investigated the activity of LDH, which catalyzes the interconversion of pyruvate and lactate involving the coenzyme NAD þ . Results showed increased LDH activity in hypothyroid hippocampus. Moreover, we observed that the increase in glucose transport coincided with an induction in LDH enzyme activity after ex vivo rT 3 treatment (Fig. 4B) . The increased LDH activity points to an enhanced glycolysis, which may be in keeping with the observation that hypothyroid condition enhanced lactate production. Therefore, we hypothesize an adaptive metabolic response after short-term rT 3 treatment in hypothyroid hippocampal cells, which may use lactate as an alternative fuel. However, it was not possible to determine the directional flow of lactate between astrocytes and neurons.
The effect of rT 3 on glucose transport as well as on LDH and AST Fig. 3 . Effect of ex vivo and in vivo treatment with rT 3 on enzymatic activity of aminotransferases and glutamine synthetase in hypothyroid hippocampus from immature rats. A and D) Enzymatic activity of alanine aminotransferase (ALT); B and E) Enzymatic activity of aspartate aminotransferase (AST); C and F) Enzymatic activity of GS. Data are reported as means ± S.E.M. of 6 animals in each group. Statistically significant differences, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: *P < 0.01; ***P < 0.0001 compared with euthyroid group; #P < 0.01; ##P < 0.001 compared with hypothyroid group.
enzymatic activities may represent a protective role of this hormone to restore, at least in part, the energy deficit in hypothyroid hippocampal cells. Glucose may be used as an energy fuel as well as may provide the carbon skeleton for synthesis of glutamate/ glutamine. In this context, AST may be involved in synthesizing glutamate from a-ketoglutarate. Taking together, our results suggest that rT 3 can help maintain the availability of the glutamateglutamine cycle by stimulating the de novo synthesis of glutamine in astrocytes as well as by interfering in other metabolic pathways.
Effect of rT 3 on glutathione levels in hypothyroid rat hippocampus
Next, we searched for GSH levels, given that glutamate is precursor of the de novo synthesis of GSH, the most important nonenzymatic antioxidant in animal tissues. Our results show decreased GSH in hypothyroid hippocampus, compatible with decreased intracellular glutamate levels and imbalanced redox equilibrium in these animals (Zamoner et al., 2008b; Cattani et al., 2013; Dasgupta et al., 2007) . Interestingly, rT 3 was able to restore the depleted GSH levels in the hypothyroid hippocampus after ex vivo and in vivo rT 3 exposure (Fig. 5A and C) .
3.6. Effect of rT 3 on gamma-glutamyl transferase activity in hypothyroid rat hippocampus
The GSH metabolism can also be modulated by GGT activity, which breaks it down, generating a g-glutamyl amino acid and cysteinyl-glycine, which are essential to GSH synthesis and homeostasis in neurons. Our results showed decreased GGT activity in hypothyroid pups, further supporting decreased GSH levels and redox imbalance in hypothyroidism (Fig. 5D) .
Next, we searched for the ex vivo and in vivo ability of rT 3 in restoring GGT activity. We found that GGT activity was totally restored by rT 3 ex vivo, but failed to be restored after the in vivo treatment, as depicted in Fig. 5B and D. The short-term action of rT 3 reinforces a nongenomic mechanism of action of this hormone on GGT activity in hypothyroid animals. Next, we searched for some signaling mechanisms that could mediate the downregulated GGT activity in hypothyroid animals as well as the metabolic action of rT 3 ex vivo. Special attention was given to clarify the nongenomic mechanism of action of this hormone.
Nongenomic mechanisms of rT 3 involved in the modulation of gamma-glutamyl transferase activity in hypothyroid hippocampus.
We searched for the molecular basis of rT 3 action on the nongenomic modulation of GGT activity, incubating hippocampal slices from euthyroid and hypothyroid pups with rT 3 in the presence or absence of enzyme inhibitors, channel blockers or receptor antagonists. Fig. 6A shows that the nongenomic effect in modulating GGT activity is specific for rT 3 and neither T 3 nor T 4 was able to modify the activity of this enzyme. It is important to consider that the thyroid hormones were used at different concentrations, ranging from 1 pM to 1 mM, and none of the concentrations tested was able to alter the baseline activity of GGT in immature euthyroid rat hippocampus (data not shown). Moreover, the decreased activity of GGT observed in hypothyroid hippocampus was not altered by T 4 or T 3 treatment. On the other hand, rT 3 significantly restored the hypothyroid GGT activity to euthyroid values, which ensures the specificity of rT 3 for nongenomic modulation of this enzyme. Taking into account the effectiveness of rT 3 in inducing nongenomic actions in hypothyroid rat hippocampus, the modulation of GGT activity was chosen to investigate the mechanism of the hormone action in this brain structure.
Farwell and colleagues suggested that an integrin might act as C-2-deoxy-D-glucose uptake (A and C) and lactate dehydrogenase activity (B) in hypothyroid rat hippocampus. Data are reported as means ± S.E.M. of 8 animals in each group. Statistically significant differences, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: *P < 0.01 compared with euthyroid group; # P < 0.05 compared with hypothyroid group. Fig. 5 . Effect of ex vivo and in vivo treatment with rT 3 on GSH levels (A and C) and on gamma-glutamyl transferase (GGT) activity (B and D) in hypothyroid hippocampus from immature rats. Data are reported as means ± S.E.M. of 8 animals in each group. Statistically significant differences, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: *P < 0.05; **P < 0.01; ***P < 0.001 compared with euthyroid group; # P < 0.05 compared with hypothyroid group. Fig. 6 . Involvement of avb3 surface receptors and Ca 2þ in the mechanism of action of rT3 on the nongenomic modulation of GGT activity in hippocampus of euthyroid and hypothyroid rats. Hippocampal slices from euthyroid and hypothyroid pups were pre-incubated for 15 min with or without 500 nM RGD (avb3 integrin receptor antagonist), 50 mM BAPTA-AM (cell-permeable Ca 2þ chelator) or 10 mM nifedipine (L-VDCC blocker). After that, the slices were incubated with or without 1 nM rT 3 , 1 nM T 4 or 100 nM T 3 for 30 min in the presence or absence of the drugs described above. Data are reported as means ± S.E.M. of 8 animals in each group. Statistically significant differences, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: *P < 0.01; **P < 0.001 compared with euthyroid group; # P < 0.05, ## P < 0.01, ### P < 0.001 compared with hypothyroid group; @ P < 0.05 compared with hypothyroid þ rT 3 group. the surface receptor for TH (Farwell et al., 1995) . In this context, a pioneer study investigating the nongenomic effects of TH in modulating angiogenesis, demonstrated that Arg-Gly-Asp (RGD) peptide blocks cell surface thyroid hormone-binding and cellular actions of the hormones (Bergh et al., 2005) . This was the first demonstration that integrin receptor avb3 at the RGD recognition site might mediate TH actions. Moreover, it is described that the binding of TH at integrin receptor avb3 can be prevented by using RGD, which is a ligand for the av integrin (Vinatier, 1995; Kumar, 1998) . In addition, RGD has been proposed as a competitive antagonist of TH action, since the hormone receptor site on the integrin was previously described to be at or very near the RGD site Cody et al., 2007) . Therefore, we searched for the involvement of the integrin receptor avb3 in the rT 3 actions using the avb3 antagonist RGD. Our results showing that the peptide RGD prevents the effect of rT 3 in modulating GGT activity are depicted in Fig. 6B . These results suggest that RGD reversibly binds to integrin receptor at the same binding site as rT 3 , reinforcing RGD as a competitive antagonist of TH action. These findings implicate the involvement of avb3 as the surface receptor for rT 3 in hypothyroid hippocampus and are in line with those from Zanatta et al. (2013) , which showed that the effect of rT 3 on 45 Ca 2þ influx in immature rat testis could be prevented by the RGD peptide. Following this rationale, we investigate the role of Ca 2þ in rT 3 -mediated effect in restoring GGT activity in hypothyroid rat hippocampus. In order to investigate the role of intracellular Ca 2þ levels and Ca 2þ influx on rT 3 -induced GGT activity in hypothyroid rat hippocampus, we used BAPTA-AM (cell-permeable Ca 2þ chelator) and nifedipine, an L-type voltage-dependent calcium channel (VDCC) blocker. Results showed that nifedipine presented an effect per se stimulating GGT activity both in euthyroid and hypothyroid rat hippocampus, while BAPTA-AM stimulated restored/induced GGT activity by itself only in hypothyroid rat hippocampus. Moreover, the effect of rT 3 in inducing/restoring GGT activity in hypothyroid rat hippocampus was unaltered by hormone co-incubation with BAPTA-AM or nifedipine (Fig. 6C) . These results indicate that restoring intracellular Ca 2þ levels could be a critical point in reestablishing the metabolic homeostasis in the hypothyroid hippocampus. However, the role played by rT 3 on GGT activity needs further investigation. Nonetheless, Meroni et al. (1997) suggest the existence of a Ca 2þ -calmodulin-dependent inhibitory pathway participating in the regulation of basal activity of GGT. Fig. 6D summarizes the involvement of Ca 2þ and avb3 surface receptor in the effect of rT 3 on GGT activity in hypothyroid rat hippocampus. Our results corroborate the inhibitory effect of Ca 2þ on the activity of GGT. These data suggest that the decreased intracellular hypothyroid Ca 2þ levels caused by the ex vivo exposure to rT 3 lead to decreased availability of this ion to bind to calmodulin, which acts as inhibitor of GGT activity. Consequently, the decreased intracellular Ca 2þ promoted by rT 3 or by using pharmacological tools (nifedipine or BAPTA-AM), leads to deactivation of the Ca 2þ -dependent inhibitory pathway on GGT activity. Thus, the ex vivo rT 3 exposure decreases Ca 2þ influx in hypothyroid hippocampus exerting a protective effect against the glutamate excitotoxicity. Taking into account that Ca 2þ may inhibit the basal activity of GGTtriggered pathways (Meroni et al., 1997) , the effect of rT 3 in decreasing Ca 2þ influx in hypothyroid hippocampus may exert a role in restoring the GGT activity to euthyroid levels. In addition, concerning the roles of Ca 2þ in the cell homeostasis, it is important to consider that this second messenger is a critical regulator of cytoskeletal dynamics. Consequently, dysregulation of Ca 2þ homeostasis is an important event in driving disruption of assembly/ disassembly equilibrium as well as the interaction of cytoskeletal proteins with regulatory proteins or cell organelles. In particular, IF proteins are directly regulated by Ca 2þ levels, which cross-link signaling cascades and connect physiological or pathological extracellular signals with the IF cytoskeleton influencing multiple aspects of cell behavior (Zamoner and Pessoa-Pureur, 2017) . Taken together, these data reinforce the potential neuroprotective activity of rT 3 on hypothyroid hippocampal cells. Fig. 7A shows that even in the presence of AP-5 (a competitive NMDA receptor antagonist) or MK-801 (uncompetitive antagonist of the NMDA receptor) rT 3 was able to increase/restore GGT activity in Fig. 7 . Involvement of NMDA glutamate receptors and intracellular signaling pathways in the mechanism of rT 3 on the nongenomic modulation of GGT activity in hippocampus of hypothyroid rats. Hippocampal slices from euthyroid and hypothyroid rats were pre-incubated for 15 min with or without 10 mM AP-5 (competitive NMDA receptor antagonist), 10 mM MK-801 (uncompetitive NMDA receptor antagonist), 10 mM H89 (PKA inhibitor), 10 mM KN93 (CaMKII inhibitor), 10 mM PD98059 (MAPK inhibitor), 10 mM SB239063 (p38 MAPK inhibitor). After that, the slices were incubated with or without 1 nM rT 3 for 30 min in the presence or absence of the drugs described above. Data are reported as means ± S.E.M. of 8 animals in each group. Statistically significant differences, as determined by one-way ANOVA followed by Tukey-Kramer multiple comparison test are indicated: *P < 0.01; **P < 0.001, ***P < 0.0001 compared with euthyroid group; # P < 0.05 compared with hypothyroid group; @ P < 0.05, @@ P < 0.01 compared with hypothyroid þ rT 3 group.
hypothyroid rat hippocampus, suggesting that NMDA glutamate receptors are not involved in the mechanisms underlying rT 3 actions. Moreover, none of those NMDA receptor antagonists was able to alter the baseline activity of GGT. We used specific kinase inhibitors to investigate the role of different protein kinases in the mechanism of rT 3 action in modulating GGT activity in hypothyroid hippocampal cells. The kinase inhibitors at the concentrations used in our experimental conditions did not alter the GGT activity by itself. As demonstrated in Fig. 7 , the concentrations used were able to prevent the rT 3 action, but ineffective in altering the baseline GGT activity both in euthyroid and in hypothyroid condition in the absence of hormone.
Experiments carried out using KN93 (Ca 2þ -calmodulin-dependent protein kinase II, PKCaMII, inhibitor) or H89 (cAMP-dependent protein kinase, PKA, inhibitor) showed that these protein kinases are implicated in the ability of rT 3 in restoring euthyroid activity of GGT (Fig. 7B) . Similarly, inhibition of the p38 mitogen-activated protein kinase (MAPK) activity by SB239063 or MEK by PD98059 prevented the action of rT 3 on GGT activity of hypothyroid pups (Fig. 7C ). Taking together, we found that rT 3 action in restoring the euthyroid GGT activity in hypothyroid pups is mediated by p38MAPK, MEK, CaMKII and PKA, as summarized in Fig. 7D . The MAPK family members have been described as modulators of the activity of TH, and different MAPKs have different roles depending on the cell type (Lei et al., 2008; Ishisaki et al., 2004; Gerges and Alkadhi, 2004; Zamoner et al., 2008b) . Our results showing a role for p38MAPK in the rT 3 -mediated modulation of GGT activity suggest that this signaling pathway could be nongenomically activated and it has a neuroprotective effect against the disrupted metabolic equilibrium induced by hypothyroidism. Fig. 9 . Proposed mechanism by which rT 3 restores the metabolic homeostasis in the hippocampus of hypothyroid developing rats. Hypothyroidism leads to disrupted GFAP homeostasis, intracellular Ca 2þ accumulation, and impaired glutamate metabolism in the hippocampus. In this scenario, we propose that the rT 3 interact with avb3 integrin receptors, thereby activating PKA, CaMKII and p38 MAPK signaling cascades. These events restore GFAP homeostasis, decreases excitotoxic Ca 2þ influx, stimulates glucose uptake and lactate production, induce GGT activity and increase the GSH levels, which were depleted by hypothyroidism. The increase in glucose uptake could represent a compensatory mechanism to the low intracellular glutamate/glutamine level. Upregulated glycolysis and lactate production suggest that rT 3 increases the availability of substrate for energy metabolism, as well as for neurotransmitter synthesis.
It is important to note that the hypophosphorylated GFAP that we found in hypothyroid pups could be ascribed to downregulate protein kinases, given that specific phosphorylating sites for PKA, CaMKII and PKC are associated with GFAP phosphorylation (Zamoner and Pessoa-Pureur, 2017) . Consequently, the restored phosphorylation level mediated by the short-term incubation with rT 3 could be related with restored kinase activities.
Moreover, the involvement of CaMKII and PKA in the mechanism of rT 3 action might improve synaptic plasticity. Vallortigara et al. (2008) described a significant increase of CaMKII levels in adult hypothyroid animals after subcutaneous injections of T 3 . It was also described that hypothyroidism impairs early long-term potentiation (LTP) in the CA1 of hippocampus and that this effect could be ascribed to reduced activity and total levels of CaMKII (Gerges et al., 2005 ) the cyclic-AMP response element-binding protein (CREB) and Erk1/2 (Alzoubi and Alkadhi, 2007) in this hippocampal region.
rT 3 interacts with avb3 integrin receptor
In order to map the potential interactions of rT 3 with avb3 integrin, the 3D structure PDB ID 1L5G was used for molecular docking analysis. Our data suggest that rT 3 was able to bind integrin receptor at RGD peptide binding site (Fig. 8) Results obtained from molecular docking suggest that the nongenomic effects of rT 3 might be triggered via a cell surface receptor for this hormone on the extracellular domain of integrin avb3.
Conclusion
Our results suggest that rT 3 , the most abundant iodothyronine during fetal life (Roti et al., 1982) , might act as a neuroprotective molecule against neurochemical misregulation induced by congenital hypothyroidism. We propose that rT 3 interacts with surface receptors (integrin avb3) in the hippocampus of hypothyroid pups restoring GFAP phosphorylation level and glutamate homeostasis to euthyroid levels through GS, AST and GGT activities. Signaling pathways involving p38MAPK, CaMKII and PKA, leading to decreased Ca 2þ influx, mediated the restored GGT activity.
Moreover, rT 3 protected hippocampal cells against redox imbalance, represented by decreased GSH and GGT. The proposed mechanism of nongenomic action for rT 3 in hippocampus of hypothyroid developing rats is depicted in Fig. 9 . We are not able to understand the reasons underlying the different ex vivo and in vivo responses of some biochemical parameters. However, our findings provide experimental evidence that rT 3 is a biologically active TH acting by nongenomic mechanisms. In addition, we hypothesize that rT 3 actions are initiated by interaction of the hormone with the integrin avb3 receptor, nongenomically modulating signaling cascades independently of gene transcription. Further studies will be needed to better understanding the mechanism of action and physiological role of rT 3 in the CNS.
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